HC Wainwright & Co. Reiterates Buy on Pharvaris, Maintains $60 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 91.3%

Neg 0% Neu 91.3% Pos 0%

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Pharvaris (NASDAQ:PHVS) with a Buy and maintains $60 price target.